GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NovoCure Ltd (NAS:NVCR) » Definitions » Cyclically Adjusted Revenue per Share

# NovoCure (NovoCure) Cyclically Adjusted Revenue per Share : \$3.50 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

## NovoCure Cyclically Adjusted Revenue per Share Definition

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

NovoCure's adjusted revenue per share for the three months ended in Dec. 2023 was \$1.251. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is \$3.50 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-04-24), NovoCure's current stock price is \$12.34. NovoCure's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was \$3.50. NovoCure's Cyclically Adjusted PS Ratio of today is 3.53.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of NovoCure was 4.73. The lowest was 3.44. And the median was 3.99.

## NovoCure Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for NovoCure's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

### NovoCure Cyclically Adjusted Revenue per Share Chart

NovoCure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial - - - - 3.50

 NovoCure Quarterly Data Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial - - - - 3.50

## Competitive Comparison of NovoCure's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, NovoCure's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

## NovoCure's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NovoCure's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where NovoCure's Cyclically Adjusted PS Ratio falls into.

## NovoCure Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is \$1 a share in 2001, then the 2001's equivalent revenue in 2010 is \$1.4 a share. If Wal-Mart's revenue is \$1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is \$1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NovoCure's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

 Adj_RevenuePerShare = Revenue per Share / CPI of Dec. 2023 (Change) * Current CPI (Dec. 2023) = 1.251 / 129.4194 * 129.4194 = 1.251

Current CPI (Dec. 2023) = 129.4194.

NovoCure Quarterly Data

 Revenue per Share CPI Adj_RevenuePerShare 201312 0.000 98.326 0.000 201406 0.000 100.560 0.000 201409 0.061 100.428 0.079 201412 0.053 99.070 0.069 201503 0.072 99.621 0.094 201506 0.079 100.684 0.102 201509 0.108 100.392 0.139 201512 0.148 99.792 0.192 201603 0.155 100.470 0.200 201606 0.210 101.688 0.267 201609 0.253 101.861 0.321 201612 0.349 101.863 0.443 201703 0.399 102.862 0.502 201706 0.435 103.349 0.545 201709 0.562 104.136 0.698 201712 0.600 104.011 0.747 201803 0.579 105.290 0.712 201806 0.674 106.317 0.820 201809 0.697 106.507 0.847 201812 0.749 105.998 0.915 201903 0.773 107.251 0.933 201906 0.900 108.070 1.078 201909 0.856 108.329 1.023 201912 0.999 108.420 1.192 202003 0.942 108.902 1.119 202006 1.077 108.767 1.281 202009 1.221 109.815 1.439 202012 1.295 109.897 1.525 202103 1.312 111.754 1.519 202106 1.290 114.631 1.456 202109 1.288 115.734 1.440 202112 1.282 117.630 1.410 202203 1.320 121.301 1.408 202206 1.346 125.017 1.393 202209 1.249 125.227 1.291 202212 1.223 125.222 1.264 202303 1.156 127.348 1.175 202306 1.186 128.729 1.192 202309 1.192 129.860 1.188 202312 1.251 129.419 1.251

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

NovoCure  (NAS:NVCR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

NovoCure's Cyclically Adjusted PS Ratio of today is calculated as

 Cyclically Adjusted PS Ratio = Share Price / Cyclically Adjusted Revenue per Share = 12.34 / 3.5 = 3.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of NovoCure was 4.73. The lowest was 3.44. And the median was 3.99.

Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.

## NovoCure Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of NovoCure's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

## NovoCure (NovoCure) Business Description

Industry
Comparable Companies
Traded in Other Exchanges